ENvue Medical Inc(FEED)
$0.26-0.02 (-6.43%)
FEED
ENvue Medical Inc financials statements
$0.26
At close:-0.02 (-6.43%)
ENvue Medical Inc (FEED) Ratios
423 Followers
ENvue Medical Inc Ratios
FEED's free cash flow for Q2 2026 was $-2.72M. For the 2026 fiscal year, FEED's free cash flow was decreased by $-27.00K and operating cash flow was $-2.69M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.09 | 1.22 | 2.64 | 2.42 | 4.38 |
| Quick Ratio | 0.74 | 0.42 | 1.53 | 1.48 | 4.29 |
| Cash Ratio | 0.63 | 0.28 | 1.34 | 1.17 | 4.07 |
| Solvency Ratio | -2.27 | -1.23 | -1.38 | -2.06 | -6.18 |
| Operating Cash Flow Ratio | -1.41 | -0.92 | -1.47 | -3.04 | -2.29 |
| Short-Term Operating Cash Flow Coverage | -8.68 | -48.38 | -720.40 | -86.85 | -89.12 |
| Net Current Asset Value | $ -356.00K | $ 329.00K | $ 3.80M | $ 2.96M | $ 6.03M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.03 | 0.03 | 0.00 | 0.01 | 0.01 |
| Debt-to-Equity Ratio | 0.04 | 0.19 | 0.00 | 0.03 | 0.01 |
| Debt-to-Capital Ratio | 0.03 | 0.16 | 0.00 | 0.02 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.23 | 5.79 | 1.67 | 1.82 | 1.37 |
| Debt Service Coverage Ratio | -12.64 | -19.81 | -13.80 | -12.73 | -291.43 |
| Interest Coverage Ratio | -40.75 | -26.53 | -13.97 | -14.44 | 0.00 |
| Debt to Market Cap | 0.54 | 0.41 | 0.07 | 1.34 | 0.91 |
| Interest Debt Per Share | 20.76 | 9.30 | 15.78 | 33.16 | 4.28 |
| Net Debt to EBITDA | 0.17 | 0.17 | 0.95 | 0.49 | 0.54 |
| Profitability Margins | |||||
| Gross Profit Margin | 5.99% | 58.95% | 67.32% | 22.21% | 45.43% |
| EBIT Margin | -724.32% | -144.10% | -150.50% | -719.81% | -840.71% |
| EBITDA Margin | -689.19% | -144.06% | -150.46% | -719.68% | -840.59% |
| Operating Profit Margin | -459.66% | -140.03% | -150.50% | -666.49% | -335.28% |
| Pretax Profit Margin | -724.32% | -144.10% | -161.28% | -719.81% | -840.71% |
| Net Profit Margin | -712.30% | -144.84% | -162.55% | -724.47% | -842.60% |
| Continuous Operations Profit Margin | -712.30% | -144.84% | -162.55% | -724.47% | -842.60% |
| Net Income Per EBT | 98.34% | 100.52% | 100.79% | 100.65% | 100.22% |
| EBT Per EBIT | 157.58% | 102.90% | 107.16% | 108.00% | 250.75% |
| Return on Assets (ROA) | -44.22% | -102.09% | -55.60% | -92.67% | -165.65% |
| Return on Equity (ROE) | -54.29% | -590.91% | -93.05% | -168.51% | -226.23% |
| Return on Capital Employed (ROCE) | -34.05% | -394.93% | -81.42% | -140.67% | -84.58% |
| Return on Invested Capital (ROIC) | -32.39% | -373.51% | -81.33% | -137.54% | -83.97% |
| Return on Tangible Assets | -237.34% | -102.09% | -55.60% | -92.67% | -165.65% |
| Earnings Yield | -917.06% | -2927.58% | -4973.34% | -9000.62% | -26625.89% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.70 | 9.54 | 5.37 | 6.90 | 6.42 |
| Payables Turnover | 3.34 | 22.34 | 5.41 | 8.86 | 10.63 |
| Inventory Turnover | 1.03 | 0.48 | 0.27 | 0.27 | 5.29 |
| Fixed Asset Turnover | 10.38 | 20.46 | 190.25 | 8.55 | 31.39 |
| Asset Turnover | 0.06 | 0.70 | 0.34 | 0.13 | 0.20 |
| Working Capital Turnover Ratio | 4.19 | 1.10 | 0.62 | 0.15 | 0.29 |
| Cash Conversion Cycle | 323.70 | 783.54 | 1337.13 | 1368.78 | 91.57 |
| Days of Sales Outstanding | 77.63 | 38.24 | 67.95 | 52.91 | 56.85 |
| Days of Inventory Outstanding | 355.42 | 761.63 | 1336.70 | 1357.05 | 69.05 |
| Days of Payables Outstanding | 109.35 | 16.34 | 67.52 | 41.18 | 34.33 |
| Operating Cycle | 433.05 | 799.87 | 1404.65 | 1409.96 | 125.90 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -131.01 | -93.24 | -226.40 | -545.10 | -381.83 |
| Free Cash Flow Per Share | -131.85 | -93.35 | -226.46 | -545.33 | -382.09 |
| Dividend Paid and CapEx Coverage Ratio | -156.20 | -838.67 | -3602.00 | -2345.00 | -1455.67 |
| Capital Expenditure Coverage Ratio | -156.20 | -838.67 | -3602.00 | -2345.00 | -1455.67 |
| Operating Cash Flow Coverage Ratio | -7.83 | -21.69 | -720.40 | -86.85 | -89.12 |
| Operating Cash Flow to Sales Ratio | -3.67 | -0.98 | -1.58 | -9.36 | -2.58 |
| Free Cash Flow Yield | -475.65% | -1990.44% | -4828.60% | -11627.46% | -8146.98% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.12 | -0.03 | -0.02 | -0.01 | -0.00 |
| Price-to-Sales (P/S) Ratio | 0.78 | 0.05 | 0.03 | 0.08 | 0.03 |
| Price-to-Book (P/B) Ratio | 0.06 | 0.20 | 0.02 | 0.02 | 0.01 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.21 | -0.05 | -0.02 | -0.01 | -0.01 |
| Price-to-Operating Cash Flow Ratio | -0.21 | -0.05 | -0.02 | -0.01 | -0.01 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 |
| Enterprise Value Multiple | 0.06 | 0.14 | 0.93 | 0.48 | 0.54 |
| Enterprise Value | -1.04M | -509.44K | -3.20M | -2.57M | -7.63M |
| EV to EBITDA | 0.06 | 0.14 | 0.93 | 0.48 | 0.54 |
| EV to Sales | -0.41 | -0.20 | -1.40 | -3.42 | -4.50 |
| EV to Free Cash Flow | 0.11 | 0.20 | 0.89 | 0.37 | 1.75 |
| EV to Operating Cash Flow | 0.11 | 0.20 | 0.89 | 0.37 | 1.75 |
| Tangible Book Value Per Share | 0.49 | 23.24 | 250.66 | 250.50 | 551.98 |
| Shareholders’ Equity Per Share | 468.25 | 23.24 | 250.66 | 250.50 | 551.98 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.02 | -0.01 | -0.01 | -0.01 | -0.00 |
| Revenue Per Share | 35.69 | 94.80 | 143.49 | 58.27 | 148.20 |
| Net Income Per Share | -254.21 | -137.30 | -233.25 | -422.13 | -1248.75 |
| Tax Burden | 0.98 | 1.01 | 1.01 | 1.01 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 1.07 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.69 | 0.36 | 0.08 | 0.38 | 0.17 |
| SG&A to Revenue | 3.97 | 1.63 | 1.72 | 5.23 | 2.98 |
| Stock-Based Compensation to Revenue | 0.00 | 0.14 | 0.13 | 0.47 | 0.23 |
| Income Quality | 0.52 | 0.68 | 0.97 | 1.29 | 0.31 |
Currency in USD
